Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 90

1.

Advanced NSCLC: from cytotoxic systemic chemotherapy to molecularly targeted therapy.

Hoang T, Schiller JH.

Expert Rev Anticancer Ther. 2002 Aug;2(4):393-401. Review.

PMID:
12647982
[PubMed - indexed for MEDLINE]
2.

Current management of advanced non-small cell lung cancer: targeted therapy.

Isobe T, Herbst RS, Onn A.

Semin Oncol. 2005 Jun;32(3):315-28. Review.

PMID:
15988686
[PubMed - indexed for MEDLINE]
3.

Novel targeted agents in the treatment of lung cancer.

Saba N, Khuri F.

Expert Opin Investig Drugs. 2004 Jun;13(6):609-29. Review.

PMID:
15174948
[PubMed - indexed for MEDLINE]
4.

Potential role of molecularly targeted therapy in the management of advanced nonsmall cell lung carcinoma in the elderly.

Gridelli C, Massarelli E, Maione P, Rossi A, Herbst RS, Onn A, Ciardiello F.

Cancer. 2004 Oct 15;101(8):1733-44. Review.

PMID:
15386339
[PubMed - indexed for MEDLINE]
Free Article
5.

Selective cyclooxygenase-2 inhibitors and non-small cell lung cancer.

Gridelli C, Maione P, Airoma G, Rossi A.

Curr Med Chem. 2002 Nov;9(21):1851-8. Review.

PMID:
12369871
[PubMed - indexed for MEDLINE]
6.

The role of new agents in the treatment of non-small cell lung cancer.

Bröker LE, Giaccone G.

Eur J Cancer. 2002 Dec;38(18):2347-61. Review.

PMID:
12460778
[PubMed - indexed for MEDLINE]
7.

Antiangiogenic agents.

Stani SC, Capaccetti B, Bonginelli P, Sarmiento R, De Sio L, Fanelli M, Gasparini G.

Suppl Tumori. 2002 Jul-Aug;1(4):S39-43. Review. No abstract available.

PMID:
12415816
[PubMed - indexed for MEDLINE]
8.

Novel therapies for the treatment of non-small cell lung cancer.

Johnson DH, Schiller JH.

Cancer Chemother Biol Response Modif. 2002;20:763-86. Review.

PMID:
12703233
[PubMed - indexed for MEDLINE]
9.

[Cyclooxygenase 2 inhibitors and lung carcinoma].

Spano JP, Chouahnia K, Morère JF.

Bull Cancer. 2004 May;91 Spec No:S109-12. Review. French.

PMID:
15239338
[PubMed - indexed for MEDLINE]
10.

New targets for the treatment of advanced non-small cell lung cancer.

Massarelli E, Onn A, Zinner R, Khuri FR, Kim ES, Herbst RS.

Cancer Chemother Biol Response Modif. 2002;20:717-61. Review. No abstract available.

PMID:
12703232
[PubMed - indexed for MEDLINE]
11.

Novel approaches to the treatment of non-small cell lung cancer.

Ferreira CG, Huisman C, Giaccone G.

Crit Rev Oncol Hematol. 2002 Jan;41(1):57-77. Review.

PMID:
11796232
[PubMed - indexed for MEDLINE]
12.

New chemotherapeutic agents: update of major chemoradiation trials in solid tumors.

Curran WJ.

Oncology. 2002;63 Suppl 2:29-38. Review.

PMID:
12466642
[PubMed - indexed for MEDLINE]
13.

COX-2 inhibition and lung cancer.

Sandler AB, Dubinett SM.

Semin Oncol. 2004 Apr;31(2 Suppl 7):45-52. Review.

PMID:
15179623
[PubMed - indexed for MEDLINE]
14.

Expression of target molecules in lung cancer: challenge for a new treatment paradigm.

Hirsch FR, Franklin WA, Bunn PA Jr.

Semin Oncol. 2002 Jun;29(3 Suppl 9):2-8. Review.

PMID:
12094332
[PubMed - indexed for MEDLINE]
15.

[New therapies for non-small cell lung cancer].

Ostoros G, Kovács G, Szondy K, Döme B.

Orv Hetil. 2005 May 22;146(21):1135-41. Review. Hungarian.

PMID:
15991677
[PubMed - indexed for MEDLINE]
16.

Novel therapies for lung cancer.

Hoang T, Traynor AM, Schiller JH.

Surg Oncol. 2002 Dec;11(4):229-41. Review.

PMID:
12450559
[PubMed - indexed for MEDLINE]
17.

Targeted therapies: focus on a new strategy for gastrointestinal tumors.

Nicolella D, Maione P, Gridelli C.

Crit Rev Oncol Hematol. 2003 Sep;47(3):261-71. Review.

PMID:
12962900
[PubMed - indexed for MEDLINE]
18.

[Cyclooxygenase 2 inhibitors and lung carcinoma].

Spano JP, Chouahnia K, Morère JF.

Bull Cancer. 2004 May;91 Suppl 2:S109-12. Review. French.

PMID:
15899634
[PubMed - indexed for MEDLINE]
19.

Targeted therapies for stage III non-small cell lung cancer: integration in the combined modality setting.

Vokes EE, Choy H.

Lung Cancer. 2003 Aug;41 Suppl 1:S115-21. Review.

PMID:
12867070
[PubMed - indexed for MEDLINE]
20.

Clinical impact of novel treatment strategies.

Giaccone G.

Oncogene. 2002 Oct 7;21(45):6970-81. Review.

PMID:
12362278
[PubMed - indexed for MEDLINE]
Free Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk